Jose A. Ainsa

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

New Chemical Scaffold with Antimicrobial Activity Identified in a Screening of Industrial Photoactive Compounds.

New Chemical Scaffold with Antimicrobial Activity Identified in a Screening of Industrial Photoactive Compounds.

Journal: Antibiotics (Basel, Switzerland)
Published: February 11, 2026

Repurposing Drugs as Bacteroides fragilis BFT-3 Inhibitors in the Animal Infection Model Galleria mellonella.

Repurposing Drugs as Bacteroides fragilis BFT-3 Inhibitors in the Animal Infection Model Galleria mellonella.

Journal: Annals of the New York Academy of Sciences
Published: September 17, 2025

The emergence of resistance to the antiparasitic selamectin in Mycobacterium smegmatis is improbable and contingent on cell wall integrity.

The emergence of resistance to the antiparasitic selamectin in Mycobacterium smegmatis is improbable and contingent on cell wall integrity.

Journal: Microbiology spectrum
Published: April 08, 2025

Magnetic hyperthermia drastically enhances killing of Mycobacterium tuberculosis by bacteriocin AS-48 grafted on biomimetic nanoparticles.

Magnetic hyperthermia drastically enhances killing of Mycobacterium tuberculosis by bacteriocin AS-48 grafted on biomimetic nanoparticles.

Journal: International journal of biological macromolecules
Published: February 12, 2025

Merging multi-omics with proteome integral solubility alteration unveils antibiotic mode of action.

Merging multi-omics with proteome integral solubility alteration unveils antibiotic mode of action.

Journal: eLife
Published: September 27, 2024

Antimicrobial combinations against Helicobacter pylori including benzoxadiazol-based flavodoxin inhibitors: in vitro characterization.

Antimicrobial combinations against Helicobacter pylori including benzoxadiazol-based flavodoxin inhibitors: in vitro characterization.

Journal: Microbiology spectrum
Published: December 12, 2023

L-Thyroxine and L-thyroxine-based antimicrobials against Streptococcus pneumoniae and other Gram-positive bacteria.

L-Thyroxine and L-thyroxine-based antimicrobials against Streptococcus pneumoniae and other Gram-positive bacteria.

Journal: Heliyon
Published: December 06, 2023

Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study.

Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study.

Journal: Antibiotics (Basel, Switzerland)
Published: December 30, 2022

Embedding Biomimetic Magnetic Nanoparticles Coupled with Peptide AS-48 into PLGA to Treat Intracellular Pathogens.

Embedding Biomimetic Magnetic Nanoparticles Coupled with Peptide AS-48 into PLGA to Treat Intracellular Pathogens.

Journal: Pharmaceutics
Published: October 15, 2022

In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae.

In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae.

Journal: Scientific reports
Published: June 02, 2022

Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme.

Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme.

Journal: European journal of medicinal chemistry
Published: January 03, 2022

Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs.

Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs.

Journal: Microorganisms
Published: October 18, 2021
Showing 1-12 of 39

Last Updated: 09/26/2026